Upon confirming the antigen specificity of the CA9 DATE for both T cells and tumor cells, we aimed to assess the efficacy of the CA9 DATE by further investigating its ability to activate and re-direct human T-cells against antigen-expressing tumor cells. Here, CA9 is linked to neoplasm.